Photodynamic therapy selectively enhances liposomal doxorubicin uptake in sarcoma tumors to rodent lungs

Lasers in Surgery and Medicine

Volumn 42, Issue 5, 2010, Pages 391-399

  Cheng, Cai ^a,b   Debefve, Elodie ^a   Haouala, Amina ^a   Andrejevic Blant, Snezana ^a   Krueger, Thorsten ^a   Ballini, Jean Pierre ^c   Peters, Solange ^a   Decosterd, Laurent ^a   Van Den Bergh, Hubert ^c   Wagnieres, Georges ^c   Perentes, Jean Y ^a   Ris, Hans Beat ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c EPFL   (Switzerland)

Author keywords

Chemotherapy; Doxorubicin; Liposomal; Lung; Photodynamic therapy; Rodents; Sarcoma; Vascular effect

Indexed keywords

DOXORUBICIN; LIPORUBICIN; UNCLASSIFIED DRUG; VERTEPORFIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG MEGADOSE; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; FLUORESCENCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOW DRUG DOSE; LUNG LOBE; LUNG PARENCHYMA; LUNG SARCOMA; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPECTROFLUOROMETRY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; LIPOSOMES; LUNG NEOPLASMS; MALE; PHOTOCHEMOTHERAPY; RATS; RATS, INBRED F344; SARCOMA;

EID: 77954392433     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20912     Document Type: Article

References (29)

1. Shibata CH, Colussi VC, Oleinick NL, Kinsella TJ. Photodynamic therapy in oncology. Exp Opin Pharmacother 2001;2:917-927.
2. Ris HB, Altermatt H, Nachbur B, Stewart C, Wang Q, Lim C, Bonnett R, Althaus U. Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies. Lasers Surg Med 1996;18:39-45.
3. Pass H, Temeck B, Krandam K, Thomas G, Russo A, Smith P, Friauf W, Steinberg S. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 1997;4:628-633. (Pubitemid 127725490)
4. Moskal TL, Dougherty TJ, Urschel JD, Antkowiak JG, Regal A-M, Driscoll DL, Takita H. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann Thorac Surg 1998;66:1128-1133.
5. Schouwink H, Rutgers ET, van der Sijp J, Oppelaar H, van Zandwijk N, van Veen R, Burgers S, Stewart FA, Zoetmulder F, Baas P. Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma. Chest 2001;20:1167-1174.
6. Friedberg JS, Mick R, Stevenson J, Metz J, Zhu T, Buyske J, Sterman DH, Pass HI, Glatstein E, Hahn SM. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thorac Surg 2003;75:952-959.
7. Pelton J, Kowalyshyn M, Keller S. Intrathoracic organ injury associated with photodynamic therapy. J Thorac Cardiovasc Surg 1992;103:1218-1223.
8. Ris HB. Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma. Lung Cancer 2005;49:65-68.
9. Henderson BW, Gollnick SO. Mechanistic principles of photodynamic therapy. In: Vo-Dinh T, editor. Biomedical Photonics Handbook. Boca Raton: CRC Press. 2003: pp 36.1-36.27.
10. Fingar VH. Vascular effects of photodynamic therapy. J Clin Laser Med Surg 1996;14:323-328.
11. Snyder JW, Greco WR, Bellnier DA, Vaughan L, Henderson BW. Photodynamic therapy: A means to enhanced drug delivery to tumors. Cancer Res 2003;63:8126-8131. (Pubitemid 37549458)
12. Debefve E, Pegaz B, Ballini JP, Konan YN, Van den Bergh H. Combination therapy using aspirin enhanced photodynamic selective drug delivery. Vasc Pharmacol 2007;46:171-180.
13. Debefve E, Pegaz B, van den Bergh H, Wagnières G, Lange N, Ballini JP. Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model. Angiogenesis 2008;11:235-243.
14. Yan H, Cheng C, Haouala A, Krueger T, Ballini JP, Peters S, Decosterd LA, Letovanec I, Ris HB, Andrejevic-Blant S. Distribution of free and liposomal doxorubicin after isolated lung perfusion in a sarcoma model. Ann Thorac Surg 2008;85:1225-1232.
15. Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 1991;88:1460-1464.
16. Gabizon AA. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 1992;52:891-896.
17. Cheng C, Haouala A, Krueger T, Mithieux F, Perentes JY, Peters S, Decosterd LA, Ris HB. Drug uptake in a rodent sarcoma model after intravenous injection or isolated lung perfusion of free/liposomal doxorubicin. Interact CardioVasc Thorac Surg 2009;8:635-638.
18. Jain RK. Normalisation of tumor vasculature: An emerging concept in antiangiogenetic therapy. Science 2005;307:58-62.
19. Fingar VH, Kik PK, Haydon PS, Cerrito PB, Tseng M, Abang E, Wieman TJ. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD). Br J Cancer 1999;79:1702-1708.
20. Pan Y, Krueger T, Tran N, Yan H, Ris HB, McKee TA. Evaluation of tumour vascularisation in two rat sarcoma models for studying isolated lung perfusion. Injection route determines the origin of tumour vessels. Eur J Surg Res 2005;37:92-99.
21. Krueger T, Pan Y, Tran N, Altermatt H, Opitz I, Ris HB. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats. Lasers Surg Med 2005;37:271-277.
22. Gabrecht T, Andrejevic-Blant S, Wagnières G. Blue-violet excited autofluorescence spectroscopy and imaging of normal and cancerous human bronchial tissue after formalin fixation. J Photochem Photobiol B 2007;83:450-458.
23. Kummerle A, Krueger T, Dusmet M, Vallet C, Pan Y, Ris HB, Decosterd LA. A validated assay for measuring doxorubicin in biological fluids and tissues in an isolated lung perfusion model: Matrix effect and heparin interference strongly influence doxorubicin measurements. J Pharm Biomed Ann 2003;33:475-494.
24. Chin DL, Lum BL, Sikic BI. Rapid determination of pegylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet visible high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2002;79:259-269.
25. Opitz I, Krueger T, Pan Y, Altermatt HJ, Wagnieres G, Ris HB. Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma. Eur Surg Res 2006;38:333-339. (Pubitemid 44154682)
26. Bessler N, Committee VSW. Verteporphin therapy in age-related macular degeneration: An open-label multicenter photodynamic study of 4435 patients. Retina 2004;20:3-7.
27. Chen B, Crane C, He C, Gondek D, Agharkar P, Savellano MD, Hoopes PJ, Pogue BW. Disparity between prostate tumor interior versus peripheral vasculature in response to verteportphyrin-mediated vascular-targeting therapy. Int J Cancer 2008;123:695-701.
28. Debefve E, Cheng C, Schaefer S, Yan H, Ballini J-P, van den Bergh H, Lehr H-A, Ruffieux C, Ris H-B, Krueger T. Visudyne-mediated photodynamic therapy enhances macromolecular delivery in normal tissue: Insights using intravital microscopy. J Photochem Photobiol B 2010;98(1):69-76.
29. Khurana M, Moriyama EH, Mariampillai A, Wilson BC. Intravital high-resolution optical imaging of individual vessel response to photodynamic treatment. J Biomed Opt 2008;13:040502.